サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1702001

ナノエマルション市場：タイプ別、投与経路別、用途別、地域別、2025-2033年

Nanoemulsion Market Report by Type, Route of Administration, Application, and Region 2025-2033

出版日
発行
IMARC
ページ情報
英文 139 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.08円
ナノエマルション市場：タイプ別、投与経路別、用途別、地域別、2025-2033年
出版日: 2025年04月01日
発行: IMARC
ページ情報: 英文 139 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

ナノエマルション市場の世界市場規模は2024年に125億米ドルに達しました。IMARC Groupは、2025年から2033年にかけての成長率（CAGR）は7.3％で、2033年には236億米ドルに達すると予測しています。市場は、栄養補助食品に対する消費者の意識の高まり、高度なドラッグデリバリーシステムに対する需要の高まり、ナノテクノロジーの研究開発活動の進行、食品・飲食品産業における製品用途の拡大によって活況を呈しています。

ナノエマルションは、界面活性剤や共界面活性剤のような乳化剤を用いて2つの混和しない液体を混合する、熱力学的に安定した等方性システムです。ナノエマルションは、安全で効果的、無毒性、非刺激性であり、表面積の大きな小さな液滴であるため、吸収性が良く、物理的安定性が向上します。その結果、医薬品有効成分のデリバリーを改善するため、医薬品システムにおいて薬剤分子のキャリアとして使用されます。また、加水分解や酸化の影響を受けやすい医薬品を保護し、医薬品の作用を長時間持続させ、細胞培養技術における油溶性サプリメントの取り込みを向上させるのにも役立っています。

ナノエマルション市場傾向：

慢性疾患の増加、スマートで精密なドラッグデリバリーシステムへの嗜好の高まりは、ナノエマルションの世界の需要を喚起する重要な要因の一つです。さらに、ナノエマルションは、様々な抗がん剤、光増感剤、治療薬の標的ドラッグデリバリーに使用されています。さらに、薬剤の治療効果を高め、副作用や毒性反応を最小限に抑えることができるため、世界中で従来のドラッグデリバリーシステムよりも支持を集めています。これとは別に、重大な健康障害に罹患しやすい高齢化人口の増加が、細網内皮系（RES）感染症の治療や肝臓の酵素補充療法におけるナノエマルションの必要性を後押ししています。このほか、化粧品やパーソナルケア産業では、フォーム、クリーム、液体、スプレーの製造に使用されています。さらに、健康志向の高まりによる機能性食品への需要の増加は、飲食品（F&B）産業におけるナノエマルションの用途にプラスの影響を与えています。ナノエマルションは、食品の消化率や有効成分の生物学的利用能の向上に役立ちます。

本レポートで扱う主な質問

  • 2024年の世界のナノエマルション市場の市場規模は？
  • 2025-2033年の世界のナノエマルション市場の予想成長率は？
  • 世界のナノエマルション市場を牽引する主要因は何か？
  • 世界のナノエマルション市場に対するCOVID-19の影響は？
  • 世界のナノエマルション市場のタイプ別内訳は？
  • 世界のナノエマルション市場の用途別内訳は？
  • 世界のナノエマルション市場における主要地域は？
  • 世界のナノエマルション市場における主要プレイヤー/企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界のナノエマルション市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：タイプ別

  • 低分子界面活性剤
  • タンパク質安定化エマルション
  • 多糖類

第7章 市場内訳：投与経路別

  • 経口
  • 非経口
  • その他

第8章 市場内訳：用途別

  • 麻酔薬
  • 抗生物質
  • 非ステロイド性抗炎症薬
  • 免疫抑制剤
  • ステロイド
  • その他

第9章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋地域
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場内訳：国別

第10章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第13章 価格分析

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Ascendia Pharmaceuticals
    • B. Braun Melsungen AG
    • BlueWillow Biologics Inc.
    • Covaris Inc.
    • Fresenius Kabi AG
    • IDEX Corporation
    • Kaken Pharmaceutical Co. Ltd.
    • Latitude Pharmaceuticals Inc.
    • Owen Biosciences Inc.
    • Santen Pharmaceutical Co. Ltd
    • Taiwan Liposome Co. Ltd.
図表

List of Figures

  • Figure 1: Global: Nanoemulsion Market: Major Drivers and Challenges
  • Figure 2: Global: Nanoemulsion Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Nanoemulsion Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Nanoemulsion Market: Breakup by Type (in %), 2024
  • Figure 5: Global: Nanoemulsion Market: Breakup by Route of Administration (in %), 2024
  • Figure 6: Global: Nanoemulsion Market: Breakup by Application (in %), 2024
  • Figure 7: Global: Nanoemulsion Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Nanoemulsion (Small-molecule Surfactant) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Nanoemulsion (Small-molecule Surfactant) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Nanoemulsion (Protein-stabilized Emulsions) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Nanoemulsion (Protein-stabilized Emulsions) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Nanoemulsion (Polysaccharide) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Nanoemulsion (Polysaccharide) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Nanoemulsion (Oral) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Nanoemulsion (Oral) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Nanoemulsion (Parenteral) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Nanoemulsion (Parenteral) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Nanoemulsion (Other Route of Administrations) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Nanoemulsion (Other Route of Administrations) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Nanoemulsion (Anesthetics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Nanoemulsion (Anesthetics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Nanoemulsion (Antibiotics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Nanoemulsion (Antibiotics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Nanoemulsion (Nonsteroidal Anti-inflammatory Drugs) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Nanoemulsion (Nonsteroidal Anti-inflammatory Drugs) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Nanoemulsion (Immunosuppressants) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Nanoemulsion (Immunosuppressants) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Global: Nanoemulsion (Steroids) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Global: Nanoemulsion (Steroids) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: Global: Nanoemulsion (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: Global: Nanoemulsion (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: North America: Nanoemulsion Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: North America: Nanoemulsion Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: United States: Nanoemulsion Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: United States: Nanoemulsion Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: Canada: Nanoemulsion Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: Canada: Nanoemulsion Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: Asia-Pacific: Nanoemulsion Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: Asia-Pacific: Nanoemulsion Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: China: Nanoemulsion Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: China: Nanoemulsion Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: Japan: Nanoemulsion Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: Japan: Nanoemulsion Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: India: Nanoemulsion Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: India: Nanoemulsion Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: South Korea: Nanoemulsion Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: South Korea: Nanoemulsion Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Australia: Nanoemulsion Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Australia: Nanoemulsion Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Indonesia: Nanoemulsion Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Indonesia: Nanoemulsion Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: Others: Nanoemulsion Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: Others: Nanoemulsion Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: Europe: Nanoemulsion Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: Europe: Nanoemulsion Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: Germany: Nanoemulsion Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: Germany: Nanoemulsion Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: France: Nanoemulsion Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: France: Nanoemulsion Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: United Kingdom: Nanoemulsion Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: United Kingdom: Nanoemulsion Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Italy: Nanoemulsion Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Italy: Nanoemulsion Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Spain: Nanoemulsion Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Spain: Nanoemulsion Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Russia: Nanoemulsion Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Russia: Nanoemulsion Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Others: Nanoemulsion Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Others: Nanoemulsion Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Latin America: Nanoemulsion Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Latin America: Nanoemulsion Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Brazil: Nanoemulsion Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Brazil: Nanoemulsion Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Mexico: Nanoemulsion Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: Mexico: Nanoemulsion Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 76: Others: Nanoemulsion Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 77: Others: Nanoemulsion Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 78: Middle East and Africa: Nanoemulsion Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 79: Middle East and Africa: Nanoemulsion Market: Breakup by Country (in %), 2024
  • Figure 80: Middle East and Africa: Nanoemulsion Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 81: Global: Nanoemulsion Industry: SWOT Analysis
  • Figure 82: Global: Nanoemulsion Industry: Value Chain Analysis
  • Figure 83: Global: Nanoemulsion Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Nanoemulsion Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Nanoemulsion Market Forecast: Breakup by Type (in Million USD), 2025-2033
  • Table 3: Global: Nanoemulsion Market Forecast: Breakup by Route of Administration (in Million USD), 2025-2033
  • Table 4: Global: Nanoemulsion Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 5: Global: Nanoemulsion Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Nanoemulsion Market: Competitive Structure
  • Table 7: Global: Nanoemulsion Market: Key Players
目次
Product Code: SR112025A4879

The global nanoemulsion market size reached USD 12.5 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 23.6 Billion by 2033, exhibiting a growth rate (CAGR) of 7.3% during 2025-2033. The market is flourished by the increasing consumer awareness about nutraceuticals, rising demand for advanced drug delivery systems, ongoing research and development (R&D) activities in nanotechnology, and expanding product applications in the food and beverage industry.

Nanoemulsions are thermodynamically stable isotropic systems wherein two immiscible liquids are mixed using an emulsifying agent like surfactant and co-surfactant. They are safe, effective, non-toxic, and non-irritant and have small-sized droplets with a greater surface area that provide better absorption and improved physical stability. As a result, they are used as carriers of drug molecules in pharmaceutical systems to improve the delivery of active pharma ingredients. They also help protect drugs that are susceptible to hydrolysis and oxidation, enable prolonged action of the medicaments, and provide better uptake of oil-soluble supplements in cell culture technology.

Nanoemulsion Market Trends:

The rising prevalence of chronic diseases, along with increasing preferences for smart and precision drug delivery systems, represents one of the key factors catalyzing the demand for nanoemulsions worldwide. Moreover, nanoemulsions are used for targeted drug delivery of various anticancer drugs, photosensitizers, and therapeutic agents. In addition, as they can enhance the therapeutic efficacy of drugs and minimize adverse effects and toxic reactions, they are gaining traction over conventional drug delivery systems across the globe. Apart from this, the growing aging population, which is more susceptible to critical health disorders, is propelling the need for nanoemulsions to treat reticuloendothelial system (RES) infection and in the enzyme replacement therapy of the liver. Besides this, they are employed in the cosmetics and personal care industries to manufacture foams, creams, liquids, and sprays. Furthermore, increasing demand for functional food on account of the rising health consciousness among individuals is positively influencing the applications of nanoemulsions in the food and beverage (F&B) industry. They assist in improving the digestibility of food and the bioavailability of active components.

Key Market Segmentation:

Breakup by Type:

  • Small-molecule Surfactant
  • Protein-stabilized Emulsions
  • Polysaccharide

Breakup by Route of Administration:

  • Oral
  • Parenteral
  • Others

Breakup by Application:

  • Anesthetics
  • Antibiotics
  • Nonsteroidal Anti-inflammatory Drugs
  • Immunosuppressants
  • Steroids
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Ascendia Pharmaceuticals, B. Braun Melsungen AG, BlueWillow Biologics Inc., Covaris Inc., Fresenius Kabi AG, IDEX Corporation, Kaken Pharmaceutical Co. Ltd., Latitude Pharmaceuticals Inc., Owen Biosciences Inc., Santen Pharmaceutical Co. Ltd and Taiwan Liposome Co. Ltd.

Key Questions Answered in This Report

  • 1.What was the size of the global nanoemulsion market in 2024?
  • 2.What is the expected growth rate of the global nanoemulsion market during 2025-2033?
  • 3.What are the key factors driving the global nanoemulsion market?
  • 4.What has been the impact of COVID-19 on the global nanoemulsion market?
  • 5.What is the breakup of the global nanoemulsion market based on the type?
  • 6.What is the breakup of the global nanoemulsion market based on the application?
  • 7.What are the key regions in the global nanoemulsion market?
  • 8.Who are the key players/companies in the global nanoemulsion market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Nanoemulsion Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Small-molecule Surfactant
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Protein-stabilized Emulsions
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Polysaccharide
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Route of Administration

  • 7.1 Oral
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Parenteral
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Others
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Anesthetics
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Antibiotics
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Nonsteroidal Anti-inflammatory Drugs
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Immunosuppressants
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Steroids
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast
  • 8.6 Other
    • 8.6.1 Market Trends
    • 8.6.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Ascendia Pharmaceuticals
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 B. Braun Melsungen AG
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 SWOT Analysis
    • 14.3.3 BlueWillow Biologics Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Covaris Inc.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Fresenius Kabi AG
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 IDEX Corporation
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Kaken Pharmaceutical Co. Ltd.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 Latitude Pharmaceuticals Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 Owen Biosciences Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Santen Pharmaceutical Co. Ltd
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Taiwan Liposome Co. Ltd.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio